Ivo P.
- Country
- Croatia
- Department
- Department for Cardiovascular Diseases
Research Overview
- Efficacy and Safety of Finerenone in Reducing Morbidity and Mortality in Heart Failure Patients with LVEF ≥40% Hospitalized for Acute Decompensated Heart Failure
- Evaluation of Finerenone Efficacy and Safety in Heart Failure Patients with Reduced Ejection Fraction Intolerant or Ineligible for Steroidal Mineralocorticoid Receptor Antagonists
Data & Insights
Has run more than one trial at 52 of 178 partner sites.
Specializations
Cardiovascular Medicine
The investigator specializes in the management and treatment of heart failure, with particular emphasis on acute decompensated heart failure conditions.
- Heart Failure with Mid-Range Ejection Fraction (HFmrEF)
- Heart Failure with Preserved Ejection Fraction (HFpEF)
- Cardiovascular Event Prevention
Their research interests encompass innovative therapeutic approaches for cardiac conditions and cardiovascular outcomes.
Clinical Cardiology
This investigator focuses on cardiovascular therapeutics and the evaluation of novel treatment strategies for heart conditions.
- Acute Cardiac Care
- Heart Failure Management
- Cardiovascular Mortality Prevention
Their clinical expertise extends to the assessment of therapeutic interventions in acute cardiac settings.
Therapeutic Innovation
The investigator's work involves evaluating novel therapeutic agents for cardiovascular conditions, particularly in acute care settings.
- Cardiac Treatment Optimization
- Therapeutic Assessment
- Clinical Outcomes Research
Their research encompasses the evaluation of treatment efficacy in cardiovascular medicine.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.